Symyx Technologies — Merger or Acquisition (May 2010)
22 slides from Symyx Technologies's merger presentation, May 27, 2010
Slide 1: Accelrys, Inc. Investor Presentation May 2010
Accelrys, Inc. Investor Presentation May 2010 Max Carnecchia, CEO Michael Piraino, CFO
Slide 2: Safe Harbor Information
Safe Harbor Information Safe Harbor Provisions When used in this presentation, words such as expects, believes, anticipates, estimates, and similar expressions identify forward-looking statements. Forward-looking statements may include statements relating to our growth strategy, the future size of o
Slide 3: Investment Summary
Investment Summary • Creates the leading enterprise scientific informatics software company • Provides the unparalleled capability of managing end-to-end scientific workflows to achieve better outcomes • Deep expertise in chemistry, biology and materials science creates a sustainable competitive adv
Slide 4: Market Environment
Market Environment
Slide 5: Scientific R&D Challenges Balance Innovation, Automation, Collaboration
Scientific R&D Challenges Balance Innovation, Automation, Collaboration Scientific innovation is not the only route to higher R&D productivity. Attention to the familiar management areas of cost, speed, and decision making can still reap rewards. Eric David, Tony Tramontin, and Rodney Zemmel McKinse
Slide 6: Today's Research & Development Challenge
Today’s Research & Development Challenge Drive Top Line Growth Drive Increased Profitability More Innovation • Increase R&D Success Rate – Re-Use Corporate Knowledge – Improve Data Modeling and Simulations – Increase Time Available for Experiments Better Productivity • Increase R&D Efficiency – Redu
Slide 7: Merger with Symyx
Merger with Symyx
Slide 8: Combining Industry Leaders
Combining Industry Leaders Founded: Public: ACCL (NASDAQ) FY Revenue: $83.0M Leading positions in: Data Collection and Analysis Data Access, Integration & Transformation Scientific Modeling and Simulation Workflow Automation and Optimization Employees: Headquarters: San Diego, CA Operations: NA, EME
Slide 9: Industry Leading Scientific Informatics Platform
Industry Leading Scientific Informatics Platform Scientific Desktop Decision Support Analytics Reporting, Visualization & Collaboration Workflow Automation Scientific Information Management Head of IT & Informatics R&D Manager Scientists VP of R&D Numeric Chemistry Chemistry Text Mining Image Analys
Slide 10: With Global Brand Customer Portfolio and Minimal Product Overlap
With Global Brand Customer Portfolio and Minimal Product Overlap Accelrys + Symyx has over 1,350 total, unique customers including • 29 of the top 30 biopharmaceutical companies • 5 of the top 5 chemical companies • 5 of the top 5 aerospace companies • 3 of the top 5 CPG companies • And major Govern
Slide 11: Scientific Informatics Software System and Partner Ecosystem
Electronic Lab Notebook Scientific Information Management Decision Support And Analytics Workflow Automation Reporting, Visualization And Collaboration Scientific Informatics Software System Vibrant & Growing Partner Ecosystem Additional applications and solutions developed by partner community More
Slide 12: Revenue Growth Drivers
Revenue Growth Drivers
Slide 13: Revenue Growth Drivers
Revenue Growth Drivers • New scientific markets • Biology/BioReg • Scientific Informatics Platform - Pipeline Pilot 8.0 • ELN – Symyx Notebook 6.4 • Professional services
Slide 14: Pipeline Pilot
Pipeline Pilot • Enterprise Scientific Data Pipelining Platform • Data collection and Integration • Analysis • Visualization • Application Deployment • Capabilities • Integration of diverse data and applications • Automated scientific data analysis and processing • Capture and deployment of best-pra
Slide 15: 2010 Symyx Market Position by Domain
ELN/ELE No. 1 Market Position No. 2 or 3 Market Position DMPK* Market Position 2010 Symyx Market Position by Domain INTRODUCTION GROWTH MATURITY 50% Product Life Cycle Stage DMPK* Formulations Bioanalytical Pharmacology Process Chemistry Synthetic Chemistry *Addressed through partnership with Symyx
Slide 16: Deal Terms & Financials
Deal Terms & Financials
Slide 17: Terms of Deal
Terms of Deal Merger Agreement Closing Exchange Ratio Ownership Market Capitalization Cash Position Approvals Expected Synergies HQ Employees Leadership Board Membership Tax-free, all stock merger of equals Expected to close early in September quarter 0.7802 Each company’s stockholders will own appr
Slide 18: Proforma Balance Sheet December 31, 2009
Proforma Balance Sheet December 31, 2009 ($ in thousands) $152 Million in Cash and No Debt Current Assets Cash & cash equivalents 133,841 $ Marketable securities 11,607 Restricted cash Trade receivables 38,972 Other current assets 22,765 207,965 Restricted cash 5,560 Property & equipment 11,256 Good
Slide 19: Proforma Income Statement – Pre Synergies
Proforma Income Statement – Pre Synergies 9 Months Ended December 31, 2009 ($ in thousands) Annualized Revenue of ~ $170 million Geographic Split: NA-50%; EMEA-30%; APAC-20% Accelrys Symyx Pro Forma Adjustments Pro Forma Combined Revenue 62,200 66,858 - 129,058 Cost of revenue 10,896 19,822 (3,771)
Slide 20: Timeline to Completion
Timeline to Completion Filing of joint proxy statement SEC no review HSR clearance Record date ACCL Board Meeting ACCL Q4/YE earnings release East coast investor trip Jefferies Life Sciences conference (NY) Shareholder’s Meetings (ACCL & SMMX) Closing 5/18-19 5/24-25
Slide 21: Focused Tactical Plan
Focused Tactical Plan From May 10, 2010
Slide 22: Accelrys, Inc. Forward-Looking Statements
Accelrys, Inc. Investor Presentation May 2010 Max Carnecchia, CEO Michael Piraino, CFO Forward-Looking Statements Certain statements in this communication may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements relate to
Symyx Technologies — Merger or Acquisition (May 2010) on 6ix